Pierre Chevalier
Université catholique de Louvain
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Pierre Chevalier.
International Journal for Quality in Health Care | 2013
Anne Spinewine; Coraline Claeys; Veerle Foulon; Pierre Chevalier
PURPOSE Medication-related problems frequently occur during transitions and lead to patient harm, increased use of healthcare resources and increased costs. The objective of this systematic review is to synthesize the impact of approaches to optimize the continuity of care in medication management upon hospital admission and/or discharge. DATA SOURCES MEDLINE, EMBASE, CINAHL, IPA and the Cochrane Database of Systematic Reviews from 1995 through December 2010. STUDY SELECTION Controlled, parallel-group trials. Data extraction Data were extracted by one researcher and checked by another. Both reviewers independently assessed the study quality. RESULTS Thirty studies met the inclusion criteria, but only 14 reached the predefined minimum quality score. Most studies focused on discharge and targeted the patients, sometimes together with primary care providers. The majority of studies found improvements in process measures. Patient education and counseling provided upon discharge and reinforced after discharge, sometimes together with improved communication with healthcare professionals, was shown to reduce the risk of adverse drug events and hospital re-admissions in some studies, but not all. Heterogeneity in study population as well as in intervention and outcome reporting precluded meta-analysis and limited interpretation. Most studies had important methodological limitations and were underpowered to show significant benefits on clinical outcomes. CONCLUSIONS The evidence for an impact of approaches on optimization of continuity of care in medication management remains limited. Further research should better target high-risk populations, use multicentered designs and have adequate sample size to evaluate the impact on process measures, clinical outcomes and cost-effectiveness.
Archive | 2006
Robert Vander Stichele; C Van De Voorde; Monique Elseviers; Charlotte Verrue; Kris Soenen; M Smet; Mirko Petrovic; Pierre Chevalier; Tom Defloor; Els Mehuys; Annemie Somers; M Gobert; M De Falleur; Marc Bauwens; Thierry Christiaens; Anne Spinewine; Stephan Devriese; Dirk Ramaekers
Archive | 2010
Anne Spinewine; Veerle Foulon; Caroline Claeys; Jan De Lepeleire; Pierre Chevalier; Siska Desplenter; Sabrina De Winter; Christophe Dumont; Valérie Lacour; Steven Simoens; Cécile Dubois; Dominique Paulus
Archive | 2010
Anne Spinewine; Veerle Foulon; Coraline Claeys; Jan De Lepeleire; Pierre Chevalier; Siska Desplenter; Sabrina De Winter; Christophe Dumont; Lacour; Steven Simoens; Cécile Dubois; Dominique Paulus
Journal de pharmacie de Belgique | 2010
Veerle Foulon; Coraline Claeys; J. De Lepeleire; Pierre Chevalier; Franciska Desplenter; S. De Winter; Christophe Dumont; Valérie Lacour; Steven Simoens; Cécile Dubois; Dominique Paulus; Anne Spinewine
Archive | 2010
Anne Spinewine; Veerle Foulon; Coraline Claeys; Jan De Lepeleire; Pierre Chevalier; Franciska Desplenter; Sabrina De Winter; Christophe Dumont; Valérie Lacour; Steven Simoens; Cécile Dubois; Dominique Paulus
Journal de pharmacie de Belgique | 2010
Veerle Foulon; Franciska Desplenter; Steven Simoens; Coraline Claeys; Dominique Paulus; Jan De Lepeleire; Pierre Chevalier; Sabrina De Winter; Catherine Dumont; Valérie Lacour; Cécile Dubois; Anne Spinewine
MINERVA (NEDERLANDSE ED.) | 2005
Marie van Driel; Pierre Chevalier
The Lancet | 2004
Marc Lemiengre; Mieke van Driel; Pierre Chevalier; Marc De Meyere; Thierry Christiaens
Quality & Safety in Health Care | 2012
Anne Spinewine; Coraline Claeys; Veerle Foulon; Pierre Chevalier